In contrast, BE from NAFLD-HCC subjects attenuated the expansion of total CD8+ T cells (CD3+CD8+) compared to both NAFLD-cirrhosis and non-NAFLD control BE (P = 0.001) (Fig. 5b). Here, CD8A is linked to metabolic dysfunction-associated steatotic liver disease.